Frequently Asked Questions: Anatomy
Is Meibomian Gland Dysfunction really present in 65% of dry eye?
Isn’t Meibomian Gland Dysfunction (MGD) just blepharitis, easily identified by obvious lid inflammation?
MGD is often less than obvious and significantly under-recognized as a factor in the dry eye cascade.
How does treating MGD with TearScience technology benefit the practice?
Dry eye patients are in the practice today. Proprietary research revealed that greater than 25% of patients at the ophthalmologist’s office had dry eye signs and symptoms; many of those were considered moderate to severe. These patients can be challenging for a practice. On average, they are provided with four to five different treatments over the course of one year. They often require considerable time and attention from the physician. Eventually, neither doctor nor patient is satisfied. Treatment of the root cause of a patient’s dry eye symptoms will change the dry eye dilemma.
Aren’t meibomian glands blocked as a result of infection or inflammation?
Sometimes, yes. Most often, no – they become blocked before any obvious sign of inflammation.